- How Kyverna rode CAR T’s autoimmune wave to the FDA’s doorPoised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.BioSpace · 5d ago↗ source
- Recon: BMS to construct AI supercomputer with Nividia; Tempus to acquire cancer diagnostic maker Personalis for $1.5B<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps · 5d ago↗ source
- Asia-Pacific Roundup: TGA seeks feedback on Australian regulations for digital mental health tools<p>Australia’s Therapeutic Goods Administration (TGA) is holding a consultation to inform changes to the regulatory framework for digital mental health tools (DMHTs).</p>